Devatis, Inc. is headquarters in South Florida. As the parent company, DEVA Holding A.S., a long established multinational company headquartered in Istanbul, Turkey which is active since 1958 in pharmaceutical sector owns 100% of Devatis, Inc. shares. In addition to its activities in Turkey and various European and significant eastern territories, DEVA Holding A.S. has stepped into the territory of the USA by incorporating Devatis Inc. In order to expand its services to human health in the US, Philipp D. Haas, having broad experience in pharmaceuticals business in various markets, is actively contributing to improve Devatis, Inc. and is acting as the President of Devatis Inc. which develops, markets and distributes quality branded pharmaceutical products directly. Devatis, Inc. adheres to strict cGMP standards and has an excellent audit history with the US Food and Drug Administration (FDA). With over 60 years of combined pharmaceutical experience in public and private sectors in more than 40 countries, the leadership team is responsible for implementing business strategy assuring long-term success. Strategic partnerships are a vital component of current and future growth.